effects [qlco]
17 beta-Estradiol [horm, phsu, strd]
Plus [qlco]
Dydrogesterone [horm, phsu, strd]
Compared [acty]
Conjugated oestrogens [horm, phsu, strd]
Equine [mamm]
medroxyprogesterone acetate [horm, phsu, strd]
Lipids [lipd]
Apolipoproteins [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
Objective [inpr]
effects [qlco]
17beta estradiol [horm, phsu, strd]
Plus [qlco]
Dydrogesterone [horm, phsu, strd]
Conjugated oestrogens [horm, phsu, strd]
Equine [mamm]
medroxyprogesterone acetate [horm, phsu, strd]
Serum lipids NOS [lbpr]
Apolipoproteins [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
postmenopausal [tmco]
Women [popg]
Methods [inpr]
Multi [qnco]
Center [spco]
prospective [resa]
DOUBLE BLIND [resa]
Comparative Study [inpr]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Aged [orga]
Intact [qlco]
Uterus [bpoc]
Fasting [fndg]
Blood sample [bdsu]
Taken [cnce]
baseline [bodm]
weeks [tmco]
treatment [ftcn]
participants [popg]
Received [qlco]
Daily [tmco]
Oral [spco]
treatment [ftcn]
Continuous [idcn]
Combined [qlco]
mg/mg [qnco]
17beta estradiol [horm, phsu, strd]
Dydrogesterone [horm, phsu, strd]
N NOS [aapp, imft]
mg% [qnco]
Conjugated [spco]
Equine [mamm]
Oestrogens [horm, phsu, strd]
mg% [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
cee [orch]
N NOS [aapp, imft]
Group [idcn]
weeks [tmco]
Observed [ftcn]
Total Cholesterol [lbpr]
1-7 [gngm]
cee [orch]
Cholesterol, LDL [bacs, strd]
4 5 [qnco]
cee [orch]
Cholesterol, HDL [bacs, lipd]
cee [orch]
Triglycerides [bacs, lipd]
cee [orch]
VLDL triglyceride [aapp, bacs, lipd]
cee [orch]
Lipoprotein (a) [aapp, bacs]
cee [orch]
Ratio [qnco]
Apolipoprotein B [aapp, bacs]
Cholesterol, LDL [bacs, strd]
cee [orch]
Conclusions [idcn]
cee [orch]
Atherogenesis [patf]
effects [qlco]
Lipids [lipd]
Lipoproteins [aapp, bacs]
Easily [qlco]
translated [ocac]
CARDIOVASCULAR [bdsy]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
